Data from clinical studies performed with a recombinant grass pollen allergy vaccine published
Allergy Research Program SFB F46
The Special Research Program SFB F46 was successfully prolonged for further four years until January 31st, 2020.
The multidisciplinary group of scientists from the Medical University of Vienna, the University of Veterinary Medicine Vienna and the Karl-Franzens-University of Graz enters the second funding period and continues their research on developing new strategies for prevention and therapy of IgE-associated allergies.
© FWF Der Wissenschaftsfonds, 2016
Within the proposed project program “Towards prevention and therapy of allergy” a multidisciplinary group of scientists has joined to develop new forms of prevention and therapy for allergy. IgE-associated allergies represent a severe health problem in industrialized countries because of their continuously increasing prevalence. Allergy affects more than 25% of the population and, if not properly diagnosed and treated, often progresses to severe and disabling manifestations such as asthma.